Amphastar Pharmaceuticals, Inc.
AMPH
$28.93
$0.1150.40%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.97% | -17.86% | 45.26% | 65.86% | 6.65% |
| Total Depreciation and Amortization | 6.35% | 6.35% | 101.47% | 88.79% | 88.22% |
| Total Amortization of Deferred Charges | -75.15% | -85.79% | -23.64% | 3,506.78% | 9,610.00% |
| Total Other Non-Cash Items | -596.37% | 470.46% | -41.21% | -53.64% | 81.58% |
| Change in Net Operating Assets | 67.88% | -27.56% | 1.85% | -3,569.19% | -94.17% |
| Cash from Operations | 21.62% | -6.80% | 25.83% | 36.92% | 56.73% |
| Capital Expenditure | -31.44% | -35.32% | 33.24% | 7.22% | -49.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 74.24% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.14% | -35.18% | 4,906.99% | 664.31% | -1,639.34% |
| Cash from Investing | 65.38% | -11.02% | 86.26% | 340.60% | -44,899.56% |
| Total Debt Issued | -- | -97.24% | -100.01% | -- | -- |
| Total Debt Repaid | 99.77% | 99.98% | 88.13% | 89.88% | -39,081.25% |
| Issuance of Common Stock | -- | -- | -- | -- | 74.68% |
| Repurchase of Common Stock | -- | 36.61% | -- | -37.61% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 104.48% | 94.38% | 100.01% | -- | -16,266.67% |
| Cash from Financing | 28.12% | -126.34% | -102.50% | -0.23% | -191.32% |
| Foreign Exchange rate Adjustments | 95.38% | -65.79% | 13.64% | -706.25% | -1,352.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.98% | -97.91% | 54.91% | 177.10% | -10,938.92% |
